MARINA BIOTECH INC Aktie

0,59 EUR -1,3289%

Zu Ihrem Onlinebroker

kaufen verkaufen

MARINA BIOTECH INC Aktienkurs : 25.05. ( 15 Min. verzögert)
0,594 € Letzter Kurs	-1,33% Veränderung	0,602 € Vortag	0,594 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
0,594 - 0,594 Tag	2,36 - 0,270 52 Wochen	0 Tag	407 Ø 52 Wochen	0,650 4.770 Stücke	0,676 4.615 Stücke

MARINA BIOTECH INC Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

23.05.

Marina Biotech, Girindus enter strategic alliance

Marina Biotech, Inc., a leading nucleic acid-based drug discovery and development company, and Girindus Group have entered into a strategic alliance where Girindus will have exclusive rights to devel…
11.05.

Monsanto Collaborates with Marina

(MON - Analyst Report) entered into an exclusive licensing agreement with Marina Biotech Inc. to support the latter's delivery and chemistry technologies. Marina Biotech Inc., a biotechnology company develops and commercializes therapeutic products ...

11.05.

Marina Biotech Receives Three Notices of Allowances From the USPTO and an ...

BOTHELL, WA--(Marketwire - May 10, 2012) - Marina Biotech, Inc. ( OTCQX : MRNA ), a leading nucleic acid-based drug discovery and development company, today announced that the US Patent and Trademark…
10.05.

Marina Biotech Receives Three Notices of Allowances From the USPTO and an ...

BOTHELL, WA, May 10, 2012 (MARKETWIRE via COMTEX) -- Marina Biotech, Inc. (otcqx:MRNA), a leading nucleic acid-based drug discovery and development company, today announced that the US Patent and Tra…
09.05.

Marina Biotech Announces Worldwide Exclusive Licensing Agreement With Monsanto

BOTHELL, WA--(Marketwire - May 8, 2012) - Marina Biotech, Inc. ( OTCQX : MRNA ) announced today that it has entered into an exclusive licensing agreement with Monsanto Company for Marina Biotech'…